ArticleInvestigative and clinical urology2026
Safety of additional intravenous acetaminophen/ibuprofen administration in patients undergoing robot-assisted renal surgery with postoperative ketorolac-based patient-controlled analgesia: A retrospective propensity-score-matched analysis.
Article in Investigative and clinical urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeNonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain management following robot-assisted renal surgery. However, concurrent dual NSAID administration raises concerns regarding an increased risk of acute kidney injury (AKI). This study evaluated the renal safety of adding an intravenous combination of acetaminophen and ibuprofen to ketorolac-based patient-controlled analgesia (PCA) in patients undergoing robot-assisted renal surgery. MATERIALS AND
methodsThis retrospective cohort study analyzed 200 adult patients who underwent robot-assisted renal surgery between September 2023 and September 2025. Patients receiving a combination of ketorolac PCA plus acetaminophen/ibuprofen (n=90, treatment group) were compared with those receiving ketorolac PCA alone (n=110, control group). After 1:1 propensity score matching, 72 patients per group were analyzed. The primary outcome was postoperative AKI diagnosed by serum creatinine changes through postoperative day 7 or until discharge, whichever occurred first.
resultsIn the matched cohort, postoperative AKI occurred in 28 patients (38.9%) in the treatment group and 32 patients (44.4%) in the control group, with no significant difference (p=0.499; risk ratio 0.89, 95% confidence interval [CI] 0.64-1.24). Serial serum creatinine trajectories were similar between groups. Multivariable logistic regression identified pneumoperitoneum duration as an independent risk factor for AKI (odds ratio 1.02, 95% CI 1.01-1.04, p=0.012), while an acetaminophen/ibuprofen combination was not associated with increased AKI risk (odds ratio 0.80, 95% CI 0.41-1.54, p=0.499).
conclusionsAdding intravenous acetaminophen/ibuprofen combination to ketorolac PCA was not significantly associated with postoperative AKI risk in patients who underwent robot-assisted renal surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.